Italy identifies corruption risks in healthcare sector

The Italian National Anti-Corruption Authority (ANAC) has released a catalog identifying corruption risks within the healthcare sector. President Giuseppe Busìa noted that healthcare accounts for approximately 25% of total public contract spending, increasing the potential for mismanagement and administrative opacity. Key risks identified include irregularities in waiting lists, favoritism in private practice within public facilities, suspicious accreditation processes for healthcare structures, and improper influence regarding the marketing and prescription of drugs and medical devices.

In related regulatory developments, the Italian Ministry of Health has established a central database to monitor medicinal packaging within the distribution system. Additionally, recent administrative updates include the extension of scientific recognition for the Synlab SDN S.r.l. diagnostic center in Naples and various resolutions from national social security and assistance entities for pharmacists, veterinarians, and medical professionals.